Publications

ESMO open

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.

01-12-2024

The Lancet. Oncology

The current and future global burden of cancer among adolescents and young adults: a population-based study.

01-12-2024

JACC. CardioOncology

Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy.

01-12-2024

Immuno-oncology technology

Integrated noninvasive diagnostics for prediction of survival in immunotherapy.

01-12-2024

Breast (Edinburgh, Scotland)

Nodal involvement in patients with small, clinically node-negative HER2-positive breast cancer after staging with FDG-PET/CT and neoadjuvant systemic therapy.

01-12-2024

Cell

P-stalk ribosomes act as master regulators of cytokine-mediated processes.

27-11-2024

Cell reports

Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas.

26-11-2024

BMC cancer

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

22-11-2024

The Journal of clinical investigation

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

19-11-2024

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey.

19-11-2024

Gynecologic and obstetric investigation

Assisted Reproductive Technology, Pregnancy, and Recurrent Disease in Melanoma Patients: A 30-Year Single Institution Experience.

15-11-2024

International journal of radiation oncology, biology, physics

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.

15-11-2024

The New England journal of medicine

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

14-11-2024

PloS one

Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors.

14-11-2024

Practical radiation oncology

Simulation of Focal Boosting in Online Adaptive MRI-Guided SBRT for Patients With Locally Advanced Prostate Cancer With Seminal Vesicle Involvement.

13-11-2024

Cell host & microbe

Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.

13-11-2024

Scientific reports

Colorectal carcinoma progression is not influenced by the pseudokinase PEAK1.

12-11-2024

JCI insight

Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.

08-11-2024

The New England journal of medicine

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

07-11-2024

Journal for immunotherapy of cancer

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

07-11-2024

Nature communications

An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer.

07-11-2024

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments.

01-11-2024

Nature genetics

Base editing screens define the genetic landscape of cancer drug resistance mechanisms.

01-11-2024

European journal of cancer (Oxford, England : 1990)

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.

01-11-2024

Health policy and technology

Perspectives on access to imaging digital health records in oncology: A mixed methods systematic review.

01-11-2024

Trends in biochemical sciences

The quest to identify ADP-ribosylation readers: methodological advances.

01-11-2024

European journal of cancer (Oxford, England : 1990)

Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.

01-11-2024

Nature medicine

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

01-11-2024

Thyroid : official journal of the American Thyroid Association

The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.

01-11-2024

European journal of cancer (Oxford, England : 1990)

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.

01-11-2024

Nature medicine

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

01-11-2024

Nature reviews. Cancer

Macrophages and T cells in metabolic disorder-associated cancers.

01-11-2024

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery.

01-11-2024

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients.

01-11-2024

Clinical lung cancer

Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.

01-11-2024

Molecular oncology

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

01-11-2024

Clinical and translational radiation oncology

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708).

01-11-2024

EMBO reports

Reduction of chromosomal instability and inflammation is a common aspect of adaptation to aneuploidy.

01-11-2024

European journal of cancer (Oxford, England : 1990)

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

01-11-2024

The EMBO journal

Chromatin protein complexes involved in gene repression in lamina-associated domains.

01-11-2024

European journal of cancer (Oxford, England : 1990)

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.

01-11-2024

Journal of cancer survivorship : research and practice

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

29-10-2024

eLife

Large-scale analysis of the integration of enhancer-enhancer signals by promoters.

28-10-2024

bioRxiv : the preprint server for biology

An integrated view of the structure and function of the human 4D nucleome.

27-10-2024

BJC reports

Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study.

23-10-2024

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Evaluating a digital tool for supporting people affected by breast cancer: a prospective randomized controlled trial-the ADAPT study.

21-10-2024

Nature communications

Cancer treatment monitoring using cell-free DNA fragmentomes.

21-10-2024

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.

20-10-2024

Journal of cancer survivorship : research and practice

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

18-10-2024

Journal of cancer survivorship : research and practice

Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.

18-10-2024

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.

The current and future global burden of cancer among adolescents and young adults: a population-based study.

Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy.

Integrated noninvasive diagnostics for prediction of survival in immunotherapy.

Nodal involvement in patients with small, clinically node-negative HER2-positive breast cancer after staging with FDG-PET/CT and neoadjuvant systemic therapy.

P-stalk ribosomes act as master regulators of cytokine-mediated processes.

Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas.

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey.

Assisted Reproductive Technology, Pregnancy, and Recurrent Disease in Melanoma Patients: A 30-Year Single Institution Experience.

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

Platinum retention in plasma, urine, and normal colonic mucosa in cisplatin-treated testicular cancer survivors.

Simulation of Focal Boosting in Online Adaptive MRI-Guided SBRT for Patients With Locally Advanced Prostate Cancer With Seminal Vesicle Involvement.

Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.

Colorectal carcinoma progression is not influenced by the pseudokinase PEAK1.

Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer.

Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments.

Base editing screens define the genetic landscape of cancer drug resistance mechanisms.

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial.

Perspectives on access to imaging digital health records in oncology: A mixed methods systematic review.

The quest to identify ADP-ribosylation readers: methodological advances.

Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Macrophages and T cells in metabolic disorder-associated cancers.

Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery.

Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients.

Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708).

Reduction of chromosomal instability and inflammation is a common aspect of adaptation to aneuploidy.

Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy.

Chromatin protein complexes involved in gene repression in lamina-associated domains.

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

Large-scale analysis of the integration of enhancer-enhancer signals by promoters.

An integrated view of the structure and function of the human 4D nucleome.

Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study.

Evaluating a digital tool for supporting people affected by breast cancer: a prospective randomized controlled trial-the ADAPT study.

Cancer treatment monitoring using cell-free DNA fragmentomes.

Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.

This site uses cookies